Orchestra BioMed (OBIO) Financials: Revenue & Earnings

OBIO price $6.00 +0.23 +3.89%

Ticker
OBIO
Price
$6.00
Change
+0.23 +3.89%
Market cap ?
$360.93M
Beta ?
0.52
Sector
Healthcare
Industry
Biotechnology

Fair value

OBIO fair value $6.39. Price $6.00. Price is 6% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 4.22M. Growth 10.23%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 60.11M. Net debt -18.73M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare OBIO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.40—129.43K
2026-08-10-0.38-0.3988.00K137.71K
2026-05-12-0.33-0.40110.00K918.71K
2026-03-120.12-0.3830.92M931.00K
2025-11-10-0.40-0.38861.00K741.40K
2025-08-12-0.50-0.51836.00K778.83K
2025-04-02-0.43-0.43253.00K522.33K
2025-03-26-0.37-0.43253.00K—
2024-11-12-0.41-0.44987.00K703.25K
2024-08-12-0.45-0.41778.00K850.00K
2024-05-13-0.38-0.40620.00K950.00K
2024-03-27-0.37-0.38262.00K994.50K
2023-11-13-0.38-0.39419.00K895.00K
2023-08-10-0.35-0.42915.00K706.00K
2023-05-12-0.40-0.281.16M680.00K
2023-01-25-2.08-3.141.10M1.18M
2022-11-14-3.71-3.141.16M1.18M
2022-08-15-0.25—401.00K—
2022-03-31-0.18—866.00K—
2021-12-31-0.00—-2.45M—
2021-09-30-0.00—1.33M—
2021-06-30-0.00—-978.00K—
2021-03-31-0.01—1.32M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Sherman DarrenSell15.00K$6.3695.40K
2026-09-10Hochman David PSell3.28K$5.8119.07K
2026-09-10Hochman David PSell3.28K$5.8119.07K
2026-09-03Hochman David PBuy10.00K$4.7947.90K
2026-09-01Sherman DarrenSell15.00K$4.9474.10K
2026-08-26Taylor Andrew LawrenceSell3.08K$5.2616.18K
2026-08-26Sherman DarrenSell4.92K$5.2625.91K
2026-08-26Sherman DarrenBuy2.00K$5.3310.66K
2026-08-26Aiello JoshuaSell203$5.261.07K
2026-08-12Pacitti DavidSell3.76K$4.4216.62K
2026-08-12Fain Eric SSell5.14K$4.4222.74K
2026-08-12Mack John ProsperSell4.88K$4.4221.59K
2026-08-12Cleary ChrisSell4.24K$4.4218.73K
2026-08-03Sherman DarrenSell15.00K$4.0961.35K
2026-07-01Sherman DarrenSell15.00K$4.2764.05K
2026-06-24Fain Eric SSell4.26K——
2026-06-24Pacitti DavidSell3.78K——
2026-06-24Cleary ChrisSell3.51K——
2026-06-24Mack John ProsperSell3.51K——
2026-06-23Fain Eric SBuy17.33K——
2026-06-23Fain Eric SBuy21.28K$4.0485.96K
2026-06-23Pacitti DavidBuy17.33K——
2026-06-23Pacitti DavidBuy21.28K$4.0485.96K
2026-06-23Cleary ChrisBuy42.55K$4.04171.91K
2026-06-23Connealy Pamela AnnBuy17.33K——
2026-06-23Connealy Pamela AnnBuy21.28K$4.0485.96K
2026-06-23Aryeh JasonBuy42.55K$4.04171.91K
2026-06-23Mack John ProsperBuy34.65K——
2026-06-10Taylor Andrew LawrenceSell36.35K$4.02146.14K
2026-06-10Hochman David PSell3.28K$4.0213.20K
2026-06-10Hochman David PSell3.28K$4.0213.20K
2026-06-01Hochman David PBuy5.00K$3.8319.15K
2026-06-01Sherman DarrenSell15.00K$3.8758.05K
2026-05-28Taylor Andrew LawrenceSell3.08K$3.9812.24K
2026-05-28Sherman DarrenSell4.92K$3.9819.60K
2026-05-18Aryeh JasonBuy665$3.752.49K
2026-05-15Aryeh JasonBuy8.97K$3.9034.99K
2026-05-15Hochman David PBuy5.00K$3.7718.85K
2026-05-14Fain Eric SBuy20.00K$4.1382.60K
2026-04-27RTW INVESTMENTS, LPBuy1.25M$0.00125
2026-04-27RTW INVESTMENTS, LPSell32$4.13132
2026-04-27RTW INVESTMENTS, LPSell1.25M$0.00125
2026-03-25Sherman DarrenSell33.32K$4.57152.26K
2026-03-25Aiello JoshuaSell241$4.571.10K
2026-03-25Hochman David PSell32.44K$4.57148.24K
2026-03-13Hochman David PBuy10.00K$4.2942.90K
2026-02-12Aiello JoshuaBuy70.00K$3.82267.40K
2026-02-12Sherman DarrenBuy397.00K——
2026-02-12Taylor Andrew LawrenceBuy181.00K——
2026-02-12Hochman David PBuy504.00K——
2026-02-05Cleary ChrisSell676$3.712.51K
2026-01-28Sherman DarrenBuy34.97K$2.8599.68K
2026-01-02Taylor Andrew LawrenceSell3.45K$4.3114.88K
2026-01-02Aiello JoshuaSell241$4.311.04K
2026-01-02Sherman DarrenSell5.59K$4.3124.08K
2025-12-10Taylor Andrew LawrenceSell8.67K$4.6740.49K
2025-12-10Hochman David PSell40.35K$4.67188.46K
2025-12-10Hochman David PSell3.28K$4.6715.33K
2025-11-25Taylor Andrew LawrenceSell3.07K$5.3516.43K
2025-11-25Sherman DarrenSell40.34K$5.35215.82K
2025-11-14Hochman David PBuy5.00K$4.0720.35K
2025-11-13Hochman David PSell3.28K$4.1813.72K
2025-11-13Hochman David PSell3.28K$4.1813.72K
2025-09-19Aryeh JasonBuy1.00K$2.452.45K
2025-09-17Aiello JoshuaSell203$2.46499
2025-09-17Taylor Andrew LawrenceSell16.10K$2.4639.61K
2025-09-17Hochman David PSell40.35K$2.4699.27K
2025-09-17Hochman David PSell3.28K$2.468.08K
2025-09-03Sherman DarrenSell40.34K$2.72109.72K
2025-08-25Fain Eric SBuy5.76K$2.6115.03K
2025-08-25Sherman DarrenBuy3.00K$2.627.86K
2025-08-25Taylor Andrew LawrenceBuy2.00K$2.555.10K
2025-08-21Hochman David PBuy6.00K$2.4914.94K
2025-08-07Taylor Andrew LawrenceBuy80.00K——
2025-08-07Aryeh JasonBuy15.00K——
2025-08-07Sherman DarrenBuy120.00K——
2025-08-07Connealy Pamela AnnBuy15.00K——
2025-08-07Mack John ProsperBuy15.00K——
2025-08-07Fain Eric SBuy7.50K——
2025-08-07Fain Eric SBuy7.50K——
2025-08-07Cleary ChrisBuy15.00K——
2025-08-07Hochman David PBuy100.00K——
2025-08-07Hochman David PBuy100.00K——
2025-08-07Pacitti DavidBuy15.00K——
2025-08-07Aiello JoshuaBuy15.00K——
2025-08-04RTW INVESTMENTS, LPBuy3.64M$0.00364
2025-08-04Hochman David PBuy20.00K$2.7555.00K
2025-08-01PERCEPTIVE ADVISORS LLCBuy700.00K$2.751.93M
2025-08-01PERCEPTIVE ADVISORS LLCBuy1.50M$0.00150
2025-06-26Fain Eric SSell2.68K$3.058.18K
2025-06-24Aryeh JasonBuy12.42K——
2025-06-24Aryeh JasonBuy36.80K$3.22118.49K
2025-06-24Cleary ChrisBuy36.80K$3.22118.49K
2025-06-24Cleary ChrisBuy12.42K——
2025-06-24Mack John ProsperBuy36.80K$3.22118.49K
2025-06-24Mack John ProsperBuy12.42K——
2025-06-24Connealy Pamela AnnBuy36.80K$3.22118.49K
2025-06-24Connealy Pamela AnnBuy12.42K——
2025-06-24Fain Eric SBuy12.42K——
2025-06-24Fain Eric SBuy36.80K$3.22118.49K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 81, holders +15 vs prior quarter. Ownership 43.95%.

HolderSharesChangeChange %Value
RTW INVESTMENTS, LP9.56M1.25M+15.05%41.23M
PERCEPTIVE ADVISORS LLC5.04M00.00%21.74M
BLACKROCK, INC.2.51M1.87M+294.89%10.83M
VANGUARD CAPITAL MANAGEMENT LLC2.02M-181.40K-8.23%8.73M
GEODE CAPITAL MANAGEMENT, LLC1.01M522.42K+107.61%4.35M
ALYESKA INVESTMENT GROUP, L.P.1.00M00.00%4.32M
PROPEL BIO MANAGEMENT, LLC896.70K00.00%3.87M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC642.15K642.15KNew2.77M
STATE STREET CORP516.05K346.64K+204.62%2.23M
RICE HALL JAMES & ASSOCIATES, LLC424.00K405.00K+2131.46%1.83M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC349.54K84.05K+31.66%1.51M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.349.54K349.54KNew1.51M
NORTHERN TRUST CORP343.64K225.37K+190.55%1.48M
UBS GROUP AG325.77K275.46K+547.53%1.41M
VANGUARD FIDUCIARY TRUST CO292.25K57.04K+24.25%1.26M
VANGUARD PORTFOLIO MANAGEMENT LLC274.97K274.97KNew1.19M
KNOTT DAVID M JR253.65K00.00%1.09M
FLAT FOOTED LLC251.37K251.37KNew1.08M
SIMPLIFY ASSET MANAGEMENT INC.219.39K00.00%946.65K
GOLDMAN SACHS GROUP INC179.61K24.36K+15.69%775.00K
DAFNA CAPITAL MANAGEMENT LLC126.84K00.00%547.32K
RENAISSANCE TECHNOLOGIES LLC90.00K19.10K+26.94%388.35K
IFP ADVISORS, INC89.61K-9.28K-9.38%386.66K
DAYTONA STREET CAPITAL LLC96.40K43.80K+83.27%379.34K
BANK OF NEW YORK MELLON CORP86.10K86.10KNew371.53K

Earnings and financials

Orchestra BioMed Holdings, Inc. (OBIO) trades at $6.00, with a market cap of $360.93M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Orchestra BioMed (OBIO) Financials: Revenue & Earnings

OBIO$6.00+0.23 +3.89%

$360.93M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History